ECTRIMS 2024 | Lower cognitive performance before MS symptom onset: a Norweigan study

Helen Tremlett, PhD, The University of British Columbia, Vancouver, Canada, discusses a study that found impaired cognitive performance up to two years before multiple sclerosis (MS) symptom onset, providing evidence for a prodromal phase in MS. Findings also suggested that those who were diagnosed with primary progressive MS had lower cognitive performance up to 10-20 years before symptom onset. This interview took place at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2024) in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.